HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip A Ades Selected Research

Enzymes

6/2012Skeletal muscle mitochondrial density, gene expression, and enzyme activities in human heart failure: minimal effects of the disease and resistance training.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip A Ades Research Topics

Disease

16Heart Failure
11/2021 - 10/2004
12Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 02/2002
11Coronary Disease (Coronary Heart Disease)
09/2016 - 02/2002
10Weight Loss (Weight Reduction)
11/2020 - 02/2002
9Insulin Resistance
11/2017 - 05/2003
8Myocardial Infarction
11/2021 - 08/2003
7Body Weight (Weight, Body)
07/2014 - 02/2002
6Obesity
01/2021 - 05/2006
5Hypertension (High Blood Pressure)
01/2019 - 04/2005
5Overweight
09/2013 - 05/2006
4Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2017 - 04/2005
4Diabetes Mellitus
09/2016 - 05/2007
3Neoplasms (Cancer)
01/2019 - 03/2015
3Inflammation (Inflammations)
01/2014 - 09/2010
2Heart Diseases (Heart Disease)
01/2019 - 01/2017
2Muscle Weakness
08/2011 - 11/2009
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2022
1COVID-19
01/2021
1Weight Gain
01/2019
1Fatigue
11/2017
1Knee Osteoarthritis
04/2017
1Systolic Heart Failure
01/2017
1Acute Coronary Syndrome
01/2017
1Type 2 Diabetes Mellitus (MODY)
09/2016
1Myalgia
02/2016
1Muscular Diseases (Myopathy)
02/2016
1Atrophy
06/2015
1Vascular Diseases (Vascular Disease)
06/2014
1Hyperlipidemias (Hyperlipidemia)
12/2011
1Malnutrition (Nutritional Deficiencies)
08/2010
1Stable Angina
11/2006
1Abdominal Obesity
04/2005

Drug/Important Bio-Agent (IBA)

8LipidsIBA
11/2017 - 05/2003
5C-Reactive ProteinIBA
11/2013 - 02/2002
4Proteins (Proteins, Gene)FDA Link
03/2012 - 01/2006
4HDL CholesterolIBA
05/2009 - 05/2003
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2016 - 08/2008
3Glucose (Dextrose)FDA LinkGeneric
11/2015 - 01/2004
2Oxygen (Dioxygen)IBA
01/2020 - 11/2008
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
06/2015 - 01/2006
2Myosins (Myosin)IBA
10/2010 - 11/2009
2Insulin (Novolin)FDA Link
08/2010 - 05/2009
2Triglycerides (Triacylglycerol)IBA
05/2009 - 04/2005
1SolutionsIBA
01/2019
1LDL CholesterolIBA
06/2014
1LDL Lipoproteins (beta Lipoproteins)IBA
06/2014
1Fibrinogen (Factor I)FDA Link
11/2013
1Tissue Plasminogen Activator (Alteplase)FDA Link
11/2013
1Adenosine Diphosphate (ADP)IBA
11/2013
1Plasminogen Activator Inhibitor 1IBA
11/2013
1P-SelectinIBA
11/2013
1EnzymesIBA
06/2012
1Muscle Proteins (Muscle Protein)IBA
08/2010
1Amino AcidsFDA Link
08/2010
1Plasminogen Activators (Plasminogen Activator)IBA
05/2009
1IS 23IBA
05/2007
1Interleukin-6 (Interleukin 6)IBA
05/2006
1CytokinesIBA
05/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2006
1Hormones (Hormone)IBA
01/2006
1Protein Isoforms (Isoforms)IBA
01/2006
1Messenger RNA (mRNA)IBA
01/2006
1oxidized low density lipoproteinIBA
05/2005
1Lipoproteins (Lipoprotein)IBA
05/2003
1CholesterolIBA
05/2002
1N 30IBA
02/2002

Therapy/Procedure

36Cardiac Rehabilitation
01/2022 - 04/2002
10Secondary Prevention
11/2019 - 04/2002
9Resistance Training
04/2017 - 02/2002
7Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022 - 06/2006
4Percutaneous Coronary Intervention
11/2021 - 11/2006
4Therapeutics
01/2019 - 03/2015
1Stents
01/2017
1Patient Readmission
01/2017
1Activities of Daily Living (ADL)
08/2011
1Tai Ji (Tai Chi Chuan)
10/2004
1Bed Rest (Bedrest)
08/2003
1Caloric Restriction
02/2002